Clinical and Radiographical Analysis of the Distal Radioulnar Joint Following Implantation of a Scheker Total Distal Radioulnar Joint Prosthesis

Overview

This project is set to describe by objective measures as the range of motion and weight-bearing ability of the distal radioulnar joint one to five years after primary implantation of a Scheker total distal radioulnar joint prosthesis.The range of motion and stability of the distal radioulnar joint (DRUJ) are important outcomes to preserve function, especially the pronation and supination. Unlike other ulnar endoprostheses that replace only the ulnar head, the Scheker prosthesis replaces the ulnar head, resurfaces the lesser sigmoid notch, and is semi-constrained in design.

Study Type

  • Study Type: Observational [Patient Registry]
  • Study Design
    • Time Perspective: Other
  • Study Primary Completion Date: June 2020

Interventions

  • Procedure: Implantation of a Scheker total distal radioulnar joint prosthesis

Clinical Trial Outcome Measures

Primary Measures

  • Primary outcomes of this study are active DRUJ range of motion (pronation and supination) and weight-bearing ability in neutral and pronated position.
    • Time Frame: Follow-up time between 12-60 months after primary implantation of the Scheker prothesis

Secondary Measures

  • Secondary outcomes of this study are radiological parameters, pain level by Visual Analog Scale, objective functional parameters (passive stability, grip strength), subjective functional parameters, and complications affecting the examined wrist.
    • Time Frame: Follow- up time between 12-60 months after primary implantation of the Scheker prothesis

Participating in This Clinical Trial

Inclusion Criteria

  • Patient treated with a Scheker total distal radioulnar joint prosthesis and with a follow-up time between 12 and 60 months after primary implantation – Patient willing and able to give written informed consent to participate in the study Exclusion criteria:

  • Inflammatory disease (e.g. rheumatoid arthritis) – Pregnant women – German language barrier to complete the questionnaires – Any disease process that would preclude accurate evaluation (e.g. neuromuscular, psychiatric or metabolic disorder) – Legal incompetence – Participation in any other medical device or medicinal product study within the previous months that could influence the results of the present study

Gender Eligibility: All

Minimum Age: N/A

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • University of Zurich
  • Provider of Information About this Clinical Study
    • Sponsor

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.